Magdi Awadalla Mohamed

8PUBLICATIONS
11CO-AUTHORS
Biomolecular modelling and designMedical biochemistry - carbohydratesMedical mycologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 26, 2025
Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations.

Tilal Elsaman, Mohamed Khalid Alhaj Awadalla, Malik Suliman Mohamed

|Jan 25, 2025
Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach.

Tilal Elsaman, Magdi Awadalla Mohamed

|Jan 11, 2025
Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors.

Magdi Awadalla Mohamed, Mohamed Khalid Alhaj Awadalla, Malik Suliman Mohamed

|Nov 06, 2024
Computational investigations of flavonoids as ALDH isoform inhibitors for treatment of cancer.

M A Mohamed, T Elsaman, M S Mohamed

|Oct 16, 2024
Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors.

Magdi Awadalla Mohamed, Tilal Elsaman, Abozer Y Elderdery

|Jun 01, 2023
Flavonostilbenes natural hybrids from Rhamnoneuron balansae as potential antitumors targeting ALDH1A1: molecular docking, ADMET, MM-GBSA calculations and molecular dynamics studies.

Tilal Elsaman, Iqrar Ahmad, Eyman Mohamed Eltayib

Pageof 2

Frequent Collaborators

6 joint publications

Tilal Elsaman

4 joint publications

Malik Suliman Mohamed

4 joint publications

Eyman Mohamed Eltayib

2 joint publications

Mohamed Khalid Alhaj Awadalla